tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kambiz Yazdi, 26 are a BUY (100%).
Analyst Kambiz Yazdi, currently employed at BTIG, carries an average stock price target met ratio of 52.69% that have a potential upside of 69.21% achieved within 213 days.
Kambiz Yazdi’s has documented 51 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on PRAX, Praxis Precision Medicines at 29-Jul-2026.
Analyst best performing recommendations are on LQDA (LIQUIDIA TECHNOLOGIES).
The best stock recommendation documented was for PRAX (PRAXIS PRECISION MEDICINES ) at 1/22/2025. The price target of $305 was fulfilled within 359 days with a profit of $225.41 (283.21%) receiving and performance score of 7.89.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Feb-2026
$362
$-13.94 (-3.71%)
$305
Buy Since 24-Jun-2024
$582
$206.06 (54.81%)
$575
Buy Since 13-Feb-2024
$810
$434.06 (115.46%)
$810
Buy Since 02-Jun-2025
$650
$322.21 (98.30%)
$750
Sell Since 04-Aug-2025
$162
$-165.79 (-50.58%)
$166
Which stock is Kambiz Yazdi is most bullish on?
Which stock is Kambiz Yazdi is most reserved on?
What Year was the first public recommendation made by Kambiz Yazdi?
